FDA Investigator Geraldine D Sanders

Geraldine D Sanders has inspections in 6 countries as of 11 Aug 2023. Geraldine D Sanders has collaborated with a combinined 3143 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
24
Last Inspection Date:
11 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
100008481
Country:
Canada, Italy, France, United States of America, Denmark, United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
A Williams, Anh M Lac, Anthony A Charity, Anthony C Warchut, Anthony C Warcnut, Arie C Menachem, Arindam Dasgupta, PhD, Arlene M Badillo, Arsen Karapetyan, Azza Talaat, Babatunde D Babalola, Beth F Fritch, Bonita S Chester, Brandon C Heitmeier, Brandy N Lepage, Brittny C Cargo, Burnell M Henry, Carl A Huffman, III, Carl Lee, Carla J Lundi, Carol F Robinson, Caryn M Everly, Caryn M Mcnab, CDR Rochelle B Young, RPh, MSA, CDR Thomas R Berry, PPh, Charles M Edwards, Charles R Cote, RIC, Chauncey A Stephens, Cherrie A Zachary, Christie A Beatty, Christie B Rice, Christopher D Leach, Christopher T Middendorf, Claire M Minden, Claudette D Brooks, Clifton C Francis, Clinton J Lott, Cynthia A Palmer, Cynthia J Lee, MS, Daryl A Dewoskin, David R Heiar, Dellarese L Herbert, Dennis Cantellops Paite, Derek C Price, Don H Bark, PhD, Donald L Lech, Dusty F Snoeberg, Edward H Maticka, Emest F Bizjak, Eric M Mueller, PharmD, Farhana Khan, Frank Wackes, Fred L Fricke, Frederick L Fricke, Frederick Razzaghi, Gabriel R Mclemore, Gamal A Norton, George J Flynn, Geraldine Sanders, Gerraldine Sanders, Gideon N Esuzor, Hai Lien T Phung, Heika R Tait, Helen B Ricalde, Ibad U Khan, Ivy E Sweeney, Jacqueline D Mitchell, James L Dunnie, Jr, James M Mason, Jamirya S Weatherly, Jaqueline Mitchell, Jared P Stevens, Jason D Abel, Jason F Chancey, Javier O Vega, Jawaid Hamid, Jeffrey A Sommers, Jennifer D Hollstrom, Jennifer L Sheehan, Joe X Phillips, Johnetta F Walters, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose R Hernandez, Joseph F Owens, Joseph X Phillips, June P Page, Karen G Hirshfield, Karen Gale Sego, Katherine Szestypalow, Kenneth H Williams, Kenneth R Merritt, Kham Phommachanh, Kim Lthomas Cruse, Laiza V Garcia, Latorie S Jones, LCDR Debra Emerson, Leah Andrews, Leah M Andrews, Lesley K Satterwhite, Libia M Lugo, LT Tamara J Henderson, Lucas B Leake, Luis M Burgos Medero, Marcia Gelber, Margaret L Bolte, Marianela Aponte Cruz, Marie A Fadden, Marie F Morin, Marvin D Jones, Melanie M Walker, Melkamu Getie Kebtie, PhD, Merril E Racke, Merril Racke, PhD, Michael A Charles, Michael R Goga, Michele Gottshall, Michele L Obert, Miguel A Martinez, Mra Davism, Mra Mcculloughj, Mra Munizn, Nadeem I Chaudhry, Patrick D Stone, MS, Patsy J Domingo, Paul L Bellamy, Paul L Figarole, Jr, Penny H Mccarver, Phillip M Pontikos, Qin Xu, Rachael L Cook, Rajiv R Srivastava, Reba A Gates, Robert C Coleman, Robert C Steyert, Robert L Lewis, Jr, Robert Sharpnack, Saleem A Akhtar, Salvatore N Randazzo, Samantha J Bradley, Samantha J Pinizzotto, D V M, Samuel L Murray, Sarah E Mcmullen, Satheesh Thomas, Sayeeda Hdabe, Sena G Dissmeyer, Shirley S Brown, Shrikant N Pagay, Simone E Pitts, Sripal R Mada, PhD, Stephen D Brown, Steven D Dittert, Steven Frisbee, Steven J Rush, Susan O Oladeji, Susanna E Ford, Analyst, Tamara M Casselman, Tammara A Stephens, Terri L Dodds, Theresa Kirkham (NMI), Thomas J Arista, Timothy T Kapsala, Tina M Pawlowski, Trang N Cox, Trang P Nguyen, Travis E Chapman, Truong Xuan Nguyen (Andy), Vanessa E Coulter, Veronica Fuentes, MS, Vickie J Kanion, Vicky C Stoakes, Vlada Matusovsky, Yumi J Hiramine, Zada L Giles

Geraldine D Sanders's Documents

Publish Date Document Type Title
March, 2001 FDA 483 Intervet Production S.A. - Form 483, 2001-03-15
February, 2001 FDA 483 Response Qualitest Pharmaceuticals - Form 483R, 2001-02-06
February, 2001 EIR Qualitest Pharmaceuticals - EIR, 2001-02-02
October, 2000 FDA 483 Watson Laboratories, Inc.-(Actavis) - Florida - Form 483, 2000-10-06
May, 2003 EIR Mikart, LLC - EIR, 2003-05-15
September, 2003 FDA 483 Poli Industria Chimica S.p.A. - Form 483, 2003-09-25
July, 2002 FDA 483 Response Raylo Chemicals Inc. - Form 483R, 2002-07-23
September, 2003 FDA 483 Response Curia Italy S.r.l. - Form 483R, 2003-10-14
August, 2001 FDA 483 Response USAntibiotics, LLC - Form 483R, 2001-09-10
July, 2002 EIR Raylo Chemicals Inc. - EIR, 2002-07-23
July, 2002 EIR Patheon Inc. - EIR, 2002-07-11
September, 2001 EIR H. Lundbeck A/S - EIR, 2001-10-04
September, 2003 FDA 483 Flamma SpA - Form 483, 2003-09-17
September, 2001 FDA 483 Response H. Lundbeck A/S - Form 483R, 2001-09-21
September, 2003 EIR Curia Italy S.r.l. - EIR, 2003-09-25
February, 2001 FDA 483 TriRx Huntsville Pharmaceutical Services, LLC - Form 483, 2001-02-02
June, 2002 EIR Bausch & Lomb Incorporated - EIR, 2002-06-10
September, 2001 EIR Shasun Pharma Solutions - EIR, 2001-09-12
July, 2002 EIR Patheon Inc. - EIR, 2002-07-17
September, 2003 FDA 483 Response Flamma SpA - Form 483R, 2003-09-26
September, 2003 EIR Flamma SpA - EIR, 2003-09-17
October, 2000 EIR Watson Laboratories, Inc.-(Actavis) - Florida - EIR, 2000-10-06
July, 2002 FDA 483 Patheon Inc. - Form 483, 2002-07-17
June, 2002 FDA 483 Response Bausch & Lomb Incorporated - Form 483R, 2002-06-28
February, 2003 FDA 483 TriRx Huntsville Pharmaceutical Services, LLC - Form 483, 2003-02-13
June, 2002 FDA 483 Bausch & Lomb Incorporated - Form 483, 2002-06-10
September, 2001 EIR H. Lundbeck A/S - EIR, 2001-10-04
August, 2001 EIR USAntibiotics, LLC - EIR, 2001-08-08
February, 2003 FDA 483 Response TriRx Huntsville Pharmaceutical Services, LLC - Form 483R, 2003-02-13

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more